Cybin D/B/A Helus Pharma (HELP.NE)
Develops psychedelic-based drugs to treat depression and anxiety disorders.
10.80-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+3.4%
The outlook
Analysts rate HELP.NE as a Strong Buy with unanimous conviction. The stock trades above both its 50- and 200-day moving averages, positioning it in the upper portion of its 52-week range. Current price sits at $10.80 with minimal daily movement.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg
Price trendAbove its 50- & 200-day averages
52-week range74% of the way from its 52-week low to high
Market cap
$669.4M
52-wk high
12.70
52-wk low
5.30
50-day avg
7.73
200-day avg
8.41
Trailing P/E
—